#causal-ai

The FDA has launched a first-of-its-kind pilot using cloud-based causal AI to shorten drug and medical device clinical trial timelines by 20–40%. FDA Chief AI Officer Jeremy Walsh says the approach could also accelerate regulatory approval timelines.